<?xml version="1.0" encoding="UTF-8"?> <!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd"> <ArticleSet> <Article> <Journal> <PublisherName>njbms</PublisherName> <JournalTitle>NJBMS</JournalTitle> <PISSN>0976-6626</PISSN> <EISSN>2455-1740</EISSN> <Volume-Issue>Volume 3, Issue 3</Volume-Issue> <PartNumber/> <IssueTopic>Multidisciplinary</IssueTopic> <IssueLanguage>English</IssueLanguage> <Season>January - March 2013</Season> <SpecialIssue>N</SpecialIssue> <SupplementaryIssue>N</SupplementaryIssue> <IssueOA>Y</IssueOA> <PubDate> <Year>-0001</Year> <Month>11</Month> <Day>30</Day> </PubDate> <ArticleType>Pathology</ArticleType> <ArticleTitle>HER-2/NEU OVEREXPRESSION IN GASTRIC ADENOCARCINOMA - AN EXPERIENCE AT TERTIARY CARE CENTRE</ArticleTitle> <SubTitle/> <ArticleLanguage>English</ArticleLanguage> <ArticleOA>Y</ArticleOA> <FirstPage>216</FirstPage> <LastPage>220</LastPage> <AuthorList> <Author> <FirstName>B.V.</FirstName> <LastName>MADHAVI</LastName> <AuthorLanguage>English</AuthorLanguage> <Affiliation/> <CorrespondingAuthor>N</CorrespondingAuthor> <ORCID/> <FirstName>B. RAVI</FirstName> <LastName>SHANKAR</LastName> <AuthorLanguage>English</AuthorLanguage> <Affiliation/> <CorrespondingAuthor>Y</CorrespondingAuthor> <ORCID/> <FirstName>B. SRIDHAR</FirstName> <LastName>REDDY</LastName> <AuthorLanguage>English</AuthorLanguage> <Affiliation/> <CorrespondingAuthor>Y</CorrespondingAuthor> <ORCID/> <FirstName>CH.</FirstName> <LastName>BALAJI</LastName> <AuthorLanguage>English</AuthorLanguage> <Affiliation/> <CorrespondingAuthor>Y</CorrespondingAuthor> <ORCID/> <FirstName>A. BHAGYA</FirstName> <LastName>LAKSHMI</LastName> <AuthorLanguage>English</AuthorLanguage> <Affiliation/> <CorrespondingAuthor>Y</CorrespondingAuthor> <ORCID/> </Author> </AuthorList> <DOI/> <Abstract>HER-2 / neu over expression in gastric adenocarcinoma is a negative prognostic factor, ranging in expression between 6-35%.The purpose of the study is to analyse the over ex pression of HER-2/neu i n G astric adenocarcinoma by IHC and confirmation by FISH. This is an analytical study from July 2008 to June 2010 in the department of pathology at a tertiary care centre. In forty two cases with diagnosis of gastric adenocarcinoma, HER -2/neu over expression was scored on IHC. Cases with HER-2/neu expression of 3+ and 2+ cases were subjected to FISH. Out of 42 cases, 36 cases showed negative HER- 2/neu expression. Two cases with IHC score of 3+ had shown amplification on FISH and 4 cases with 2+ score did not show any amplification. In the present study HER- 2/neu over expression was seen in 5% of gastric adenocarcinoma. All cases with IHC score 3+ showed HER-2/neu amplification on FISH.</Abstract> <AbstractLanguage>English</AbstractLanguage> <Keywords>Gastric adenocarcinoma, HER-2/neu, Immunohistochemistry (IHC), Fluorescence in situ Hybridization (FISH).</Keywords> <URLs> <Abstract>https://njbms.in/ubijournal-v1copy/journals/abstract.php?article_id=1648&title=HER-2/NEU OVEREXPRESSION IN GASTRIC ADENOCARCINOMA - AN EXPERIENCE AT TERTIARY CARE CENTRE</Abstract> </URLs> <References> <ReferencesarticleTitle>References</ReferencesarticleTitle> <ReferencesfirstPage>16</ReferencesfirstPage> <ReferenceslastPage>19</ReferenceslastPage> <References/> </References> </Journal> </Article> </ArticleSet>